跳转至内容
Merck
CN

V800203

盐酸

35-37%, Analytical Reagent (AR)

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
HCl
化学文摘社编号:
分子量:
36.46
UNSPSC Code:
12352300
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
1098214
Concentration:
35-37%
Form:
liquid
Grade:
AR
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

盐酸, AR, 35-37%

grade

AR

vapor density

1.3 (vs air)

vapor pressure

3.23 psi ( 21.1 °C), 7.93 psi ( 37.7 °C)

product line

Vetec

form

liquid

concentration

35-37%

pH

<1.0

bp

>100 °C (lit.)

density

1.18 g/mL at 20 °C

SMILES string

Cl

InChI

1S/ClH/h1H

InChI key

VEXZGXHMUGYJMC-UHFFFAOYSA-N

Legal Information

Vetec is a trademark of Merck KGaA, Darmstadt, Germany


Still not finding the right product?

Explore all of our products under 盐酸


pictograms

CorrosionExclamation mark

signalword

Danger

Hazard Classifications

Eye Dam. 1 - Met. Corr. 1 - Skin Corr. 1B - STOT SE 3

target_organs

Respiratory system

存储类别

8B - Non-combustible corrosive hazardous materials

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Douglas M McMillan et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(7), 1804-1812 (2015-01-30)
CYP2D metabolically activates codeine to morphine, which is required for codeine analgesia. Permeability across the blood-brain barrier, and active efflux, suggests that initial morphine in the brain after codeine is due to brain CYP2D metabolism. Human CYP2D is higher in
Marta Kolodziejczak et al.
ACS chemical neuroscience, 6(7), 1219-1230 (2015-04-11)
Maturation of functional neuronal circuits during central nervous system development relies on sophisticated mechanisms. First, axonal and dendritic growth should reach appropriate targets for correct synapse elaboration. Second, pruning and neuronal death are required to eliminate redundant or inappropriate neuronal
Jay G Hosking et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(4), 1005-1015 (2014-10-21)
Successful decision making often requires weighing a given option's costs against its associated benefits, an ability that appears perturbed in virtually every severe mental illness. Animal models of such cost/benefit decision making overwhelmingly implicate mesolimbic dopamine in our willingness to



全球贸易项目编号

货号GTIN
V800203-8X500ML04061838157942
V800203-2X5L04061838157928
V800203-6X500ML04061837815386
V800203-4X5L04061838167125
V800203-4X2.5L04061838157935